プリルの世界市場2023

Market Research Futureが発行した調査報告書(MRF9DC118)
◆英語タイトル:Global Prils Market Research Report Forecast to 2023
◆商品コード:MRF9DC118
◆発行会社(リサーチ会社):Market Research Future
◆発行日:2019年6月
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Online Access)USD4,450 ⇒換算¥485,050見積依頼/購入/質問フォーム
Enterprisewide Price(印刷可)USD6,250 ⇒換算¥681,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Research Future社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Research Future社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、プリルの世界市場について調査・分析し、エグゼクティブサマリ-、市場紹介、調査方法、市場動向、市場要因分析、タイプ別(ラミプリル、キナプリル、シラザプリル、ベナゼプリル)分析、用途別(高血圧、心不全、慢性腎障害)分析、地域別分析、競合分析、会社概要などを含め、以下の構成でお届けします。
・エグゼクティブサマリ-
・市場紹介
・調査方法
・市場動向
・市場要因分析
・プリルの世界市場:タイプ別(ラミプリル、キナプリル、シラザプリル、ベナゼプリル)
・プリルの世界市場:用途別(高血圧、心不全、慢性腎障害)
・プリルの世界市場:地域別分析
・競合分析
・会社概要
【レポートの概要】

Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, & the Middle East & Africa) – Global Forecast till 2023
Market analysis

The global prils market incorporates active pharmaceutical ingredients (APIs) fixings. APIs are naturally dynamic fixings or substances which are significant the piece of any medication. There are distinctive APIs accessible with various properties, and they are utilized by pharmaceutical, biotech, and nourishing enterprises appropriately to grow new items. The key variables in charge of driving the market are expanding the commonness of heart illnesses, hypertension and kidney related issues, rising geriatric populace, developing the significance of nonexclusive medications, and furthermore the general take-up of the biopharmaceuticals business. Notwithstanding, factors, for example, negative medication cost-control arrangements in numerous nations, expanding infiltration of fake medications, and complex permit reestablishment systems hamper the market development. The global prils market is anticipated to grow at CAGR of 4.3% to reach the valuation of USD 2,591.5 million till the year 2023.

Market segmentation

The global prils market is segmented on the basis of its type, application, and regional demand. Based on its type, the global prils market is categorized into Quinapril, Ramipril, Benazepril, and Cilazapril. The global prils market is segmented on the basis of its application, is divided into heart failure, hypertension, chronic kidney disorders, and others.

Regional analysis

Geographically, the global prils market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, among others are some of the major players in the global prils market.

【レポートの目次】

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Scope of the Study
2.2 Research Objective
2.3 List of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Pharmaceutical Industry
4.2.2 Growing Prevalence of Chronic Diseases Across the World
4.2.3 Growing Importance of Generic Drugs
4.3 Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 Adverse Drug Price Control Policies Across Numerous Countries
4.4 Opportunity
4.4.1 Development of New Drugs
4.5 Product Pipeline Analysis
4.5.1 Introduction
4.5.2 NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
4.5.3 Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
4.5.4 Ramipril Treatment of Claudication
4.5.5 Bariatric Surgery and Pharmacokinetics of Ramipril
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Marketing & Sales
5.1.5 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.5 Intense Rivalry
5.3 Specifications & Purity Requirements
5.4 Patent Analysis
5.4.1 Introduction
5.4.2 Patent Analysis for Benazepril
5.4.2.1 Process for Preparation of Benazepril
5.4.3 Patent Analysis for Cilazapril
5.4.3.1 Process for Preparation of Enantiomerically Pure Cilazapril
5.4.3.2 Process for the Preparation of Cilazapril
5.4.3.3 Process for the Preparation of an Intermediate of Cilazapril
5.4.4 Patent Analysis of Quinapril
5.4.4.1 Methods for the Preparation of Quinapril
5.4.4.2 Methods for the Preparation of Quinapril Hydrochloride
5.4.4.3 Process for the Preparation of Highly Pure Crystalline Quinapril Hydrochloride
5.4.4.4 Formulations of Quinapril and Related Ace Inhibitors
5.4.5 Patent Analysis for Ramipril
5.4.5.1 Formulations of Ramipril
5.4.5.2 Stabilized Individually Coated Ramipril Particles, Compositions, and Methods
5.4.5.3 Use of Ramipril in the Prevention of Congestive Heart Failure
5.5 Regulatory Analysis
5.6 Pricing Evolution
6 Global Prils Market, by Type
6.1 Introduction
6.2 Ramipril
6.3 Quinapril
6.4 Cilazapril
6.5 Benazepril
7 Global Prils Market, by Application
7.1 Introduction
7.2 Hypertension
7.3 Heart Failure
7.4 Chronic Kidney Disorders
8 Global Prils Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 UK
8.3.1.3 France
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.1.7 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Competitive landscape
9.1 Introduction
9.2 Key developments
10 Company Profiles
10.1 Aurobindo Pharma
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategies
10.2 Lupin
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategies
10.3 Pfizer, Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategies
10.4 Mylan N.V.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategies
10.5 F. Hoffmann-La Roche
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategies
10.6 Sun Pharmaceutical Industries Ltd
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategies
10.7 Merck KGaA
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategies
10.8 Manus Aktteva Biopharma LLP
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategies
10.9 Canagen Pharmaceuticals Inc.
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategies
10.1 Novartis AG
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategies
11 Appendix
References
Related Reports

List of Tables:

TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 PRILS MARKET: PRODUCT PIPELINE ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET
TABLE 5 PATENT ANALYSIS FOR BENAZEPRIL
TABLE 6 PATENT ANALYSIS FOR CILAZAPRIL
TABLE 7 PATENT ANALYSIS FOR QUINAPRIL
TABLE 8 PATENT ANALYSIS FOR RAMIPRIL
TABLE 9 AMERICAS: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 10 EUROPE: AVERAGE SELLING PRICE (ASP) ,BY TYPE, (USD/KG) 2018
TABLE 11 ASIA-PACIFIC: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 12 MIDDLE EAST: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 13 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 14 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 15 GLOBAL PRILS MARKET, FOR RAMIPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 16 GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 17 GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 18 GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 19 GLOBAL PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 20 GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 21 GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 22 GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 23 GLOBAL PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 24 AMERICAS: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 25 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 26 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 27 AMERICAS: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 28 NORTH AMERICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 29 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 30 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 31 NORTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 32 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 33 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 34 US: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 35 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 36 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 37 CANADA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 38 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 39 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 40 SOUTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 41 EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 42 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 43 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 44 EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 45 WESTERN EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 46 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 47 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 48 WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 49 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 50 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 51 GERMANY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 52 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 53 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 54 UK: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 55 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 56 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 57 FRANCE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 58 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 59 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 60 ITALY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 61 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 62 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 63 SPAIN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 64 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 65 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 66 REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 67 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 68 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 69 EASTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 70 ASIA-PACIFIC: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 71 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 72 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 73 ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 74 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 75 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 76 JAPAN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 77 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 78 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 79 CHINA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 80 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 81 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 82 INDIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 83 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 84 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 85 AUSTRALIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 86 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 87 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 88 SOUTH KOREA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 89 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 91 REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 95 MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 96 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 97 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 98 MIDDLE EAST: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 99 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 100 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 101 AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 102 MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET
TABLE 103 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

List of Figures:

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PRILS MARKET: STRUCTURE
FIGURE 3 RESEARCH PROCESS
FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET
FIGURE 6 VALUE CHAIN: GLOBAL PRILS MARKET
FIGURE 7 GLOBAL PRILS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL PRILS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 10 AMERICAS: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 11 NORTH AMERICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 12 EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 13 WESTERN EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 14 ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15 MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 16 CATEGORY WISE SHARE OF KEY DEVELOPMENTS

【掲載企業】

Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ プリルの世界市場2023(Global Prils Market Research Report Forecast to 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆